Learning Objectives:

1) Recognize how older adults with kidney disease are a vulnerable population who are at increased risk for adverse medication safety events.

2) Understand how pharmacoepidimiology studies can improve our understanding of medication safety in older adults with kidney disease.

3) Learn about clinical innovation efforts to improve medication management in older adults with kidney disease.

Julie F Paik, MD, Presenter, has no relevant financial relationships to disclose.